macropen 35 mg/ml zrnca za peroralno suspenzijo
krka, d.d., novo mesto - miokamicin - zrnca za peroralno suspenzijo - miokamicin 35 mg / 1 ml - miokamicin
macropen 400 mg filmsko obložene tablete
krka, d.d., novo mesto - midekamicin - filmsko obložena tableta - midekamicin 400 mg / 1 tableta - midekamicin
microlax 4,465 g/0,45 g/0,0645 g rektalna raztopina
natrijev citrat; sorbitol, tekoči (kristalizirajoči); natrijev lavrilsulfoacetat (70%) - rektalna raztopina - natrijev citrat 0,45 g / 1 vsebnik sorbitol, tekoči (kristalizirajoči)4,465 g / 1 vsebnik natrijev lavrilsulfoacetat (70%)0,0645 g / 1 vsebnik; sorbitol, tekoči (kristalizirajoči) 4,465 g / 1 vsebnik natrijev lavrilsulfoacetat (70%)0,0645 g / 1 vsebnik; natrijev lavrilsulfoacetat (70%) 0,0645 g / 1 vsebnik - natrijev lavrilsulfoacetat in njegove kombinacije
microlax 4,465 g/0,45 g/0,0645 g rektalna raztopina
natrijev citrat; sorbitol, tekoči (kristalizirajoči); natrijev lavrilsulfoacetat (70%) - rektalna raztopina - natrijev citrat 0,45 g / 1 vsebnik sorbitol, tekoči (kristalizirajoči)4,465 g / 1 vsebnik natrijev lavrilsulfoacetat (70%)0,0645 g / 1 vsebnik; sorbitol, tekoči (kristalizirajoči) 4,465 g / 1 vsebnik natrijev lavrilsulfoacetat (70%)0,0645 g / 1 vsebnik; natrijev lavrilsulfoacetat (70%) 0,0645 g / 1 vsebnik - natrijev lavrilsulfoacetat in njegove kombinacije
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
angiox
the medicines company uk ltd - bivalirudin - akutni koronarni sindrom - antitrombotična sredstva - angiox je indiciran kot antikoagulant pri odraslih bolnikih s perkutano koronarnim posegom (pci), vključno z bolniki z miokardnim infarktom elevacije st (stemi), ki se podvrže primarni pci. angiox je prikazano tudi za zdravljenje odraslih bolnikov z nestabilno angino pektoris / non-st-segmenta,-dvig miokardni infarkt (ua / nstemi) načrtovana za nujne ali zgodnje intervencije. angiox je treba dajati z aspirinom in clopidogrel.